share_log

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A: Preliminary proxy statements relating to merger or acquisition

PRE 14A：並購重組委托聲明
美股SEC公告 ·  10/17 05:18

Moomoo AI 已提取核心訊息

Conduit Pharmaceuticals Inc. has announced a virtual annual meeting of stockholders scheduled for December 18, 2024. The meeting will address the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and a proposed amendment to authorize a reverse stock split of common stock shares. The reverse stock split ratio will be set by the Board within a range of 1-for-10 to 1-for-100. The meeting is exclusively virtual, with stockholders able to participate and vote during the live webcast by registering in advance. The record date for stockholder entitlement to notice and vote is October 25, 2024. The company has also filed a preliminary proxy statement with the SEC, detailing the agenda and providing information on how stockholders can vote their shares.
Conduit Pharmaceuticals Inc. has announced a virtual annual meeting of stockholders scheduled for December 18, 2024. The meeting will address the election of six directors, the ratification of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and a proposed amendment to authorize a reverse stock split of common stock shares. The reverse stock split ratio will be set by the Board within a range of 1-for-10 to 1-for-100. The meeting is exclusively virtual, with stockholders able to participate and vote during the live webcast by registering in advance. The record date for stockholder entitlement to notice and vote is October 25, 2024. The company has also filed a preliminary proxy statement with the SEC, detailing the agenda and providing information on how stockholders can vote their shares.
Conduit Pharmaceuticals Inc.宣佈將於2024年12月18日舉行一次虛擬股東年會。會議將討論選舉六位董事、批准Marcum LLP爲截至2024年12月31日財政年度的獨立註冊會計師事務所，以及擬議的授權進行普通股股票的逆向股票拆分修正案。逆向股票拆分比率將由董事會在1∶10至1∶100的區間內確定。會議完全是虛擬的，股東可以提前註冊以參與和投票，在現場網絡直播中進行。股東通知和投票的記載日期爲2024年10月25日。該公司還向美國證券交易委員會提交了一份初步的代理聲明，詳細說明了議程，並提供了股東如何投票的信息。
Conduit Pharmaceuticals Inc.宣佈將於2024年12月18日舉行一次虛擬股東年會。會議將討論選舉六位董事、批准Marcum LLP爲截至2024年12月31日財政年度的獨立註冊會計師事務所，以及擬議的授權進行普通股股票的逆向股票拆分修正案。逆向股票拆分比率將由董事會在1∶10至1∶100的區間內確定。會議完全是虛擬的，股東可以提前註冊以參與和投票，在現場網絡直播中進行。股東通知和投票的記載日期爲2024年10月25日。該公司還向美國證券交易委員會提交了一份初步的代理聲明，詳細說明了議程，並提供了股東如何投票的信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間